Logo image of EMD

WESTERN ASSET EMRG MRKT DBT (EMD) Stock Price, Quote, News and Overview

NYSE:EMD - New York Stock Exchange, Inc. - US95766A1016 - Currency: USD

10.11  +0.03 (+0.3%)

After market: 10.11 0 (0%)

Fundamental Rating

2

Taking everything into account, EMD scores 2 out of 10 in our fundamental rating. EMD was compared to 0 industry peers in the Unkown industry. EMD may be in some trouble as it scores bad on both profitability and health. EMD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year EMD was profitable.
In the past year EMD had a positive cash flow from operations.
In multiple years EMD reported negative net income over the last 5 years.
Each year in the past 5 years EMD had a positive operating cash flow.
EMD Yearly Net Income VS EBIT VS OCF VS FCFEMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M

1.2 Ratios

Industry RankSector Rank
ROA 8.19%
ROE 11.56%
ROIC 3.92%
ROA(3y)-4.11%
ROA(5y)0.31%
ROE(3y)-5.67%
ROE(5y)0.48%
ROIC(3y)4.01%
ROIC(5y)3.96%
EMD Yearly ROA, ROE, ROICEMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

EMD's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of EMD has declined.
In the last couple of years the Gross Margin of EMD has declined.
Industry RankSector Rank
OM 65.77%
PM (TTM) 108.65%
GM 66.08%
OM growth 3Y-5.61%
OM growth 5Y-2.37%
PM growth 3Y19.94%
PM growth 5YN/A
GM growth 3Y-5.63%
GM growth 5Y-2.25%
EMD Yearly Profit, Operating, Gross MarginsEMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for EMD has been reduced compared to 1 year ago.
The number of shares outstanding for EMD has been reduced compared to 5 years ago.
EMD has a worse debt/assets ratio than last year.
EMD Yearly Shares OutstandingEMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
EMD Yearly Total Debt VS Total AssetsEMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

2.2 Solvency

Based on the Altman-Z score of 1.03, we must say that EMD is in the distress zone and has some risk of bankruptcy.
EMD has a debt to FCF ratio of 4.92. This is a neutral value as EMD would need 4.92 years to pay back of all of its debts.
EMD has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 4.92
Altman-Z 1.03
ROIC/WACCN/A
WACCN/A
EMD Yearly LT Debt VS Equity VS FCFEMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.03 indicates that EMD may have some problems paying its short term obligations.
EMD has a Quick Ratio of 0.03. This is a bad value and indicates that EMD is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
EMD Yearly Current Assets VS Current LiabilitesEMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 149.96% over the past year.
EMD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.13% yearly.
Looking at the last year, EMD shows a quite strong growth in Revenue. The Revenue has grown by 8.04% in the last year.
Measured over the past years, EMD shows a decrease in Revenue. The Revenue has been decreasing by -5.61% on average per year.
EPS 1Y (TTM)149.96%
EPS 3Y16.13%
EPS 5YN/A
EPS Q2Q%14.91%
Revenue 1Y (TTM)8.04%
Revenue growth 3Y-4.32%
Revenue growth 5Y-5.61%
Sales Q2Q%10.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMD Yearly Revenue VS EstimatesEMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.15, the valuation of EMD can be described as very reasonable.
Compared to an average S&P500 Price/Earnings ratio of 27.25, EMD is valued rather cheaply.
Industry RankSector Rank
PE 8.15
Fwd PE N/A
EMD Price Earnings VS Forward Price EarningsEMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 11.56
EV/EBITDA N/A
EMD Per share dataEMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.59%, EMD is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.34, EMD pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.59%

5.2 History

The dividend of EMD decreases each year by -5.11%.
EMD has been paying a dividend for at least 10 years, so it has a reliable track record.
EMD has decreased its dividend recently.
Dividend Growth(5Y)-5.11%
Div Incr Years1
Div Non Decr Years1
EMD Yearly Dividends per shareEMD Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

76.80% of the earnings are spent on dividend by EMD. This is not a sustainable payout ratio.
DP76.8%
EPS Next 2YN/A
EPS Next 3YN/A
EMD Yearly Income VS Free CF VS DividendEMD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M
EMD Dividend Payout.EMD Dividend Payout, showing the Payout Ratio.EMD Dividend Payout.PayoutRetained Earnings

More info and screens

WESTERN ASSET EMRG MRKT DBT

NYSE:EMD (7/31/2025, 8:20:27 PM)

After market: 10.11 0 (0%)

10.11

+0.03 (+0.3%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)03-03 2025-03-03
Earnings (Next)08-26 2025-08-26
Inst Owners46.79%
Inst Owner Change0.25%
Ins Owners0%
Ins Owner Change12.65%
Market Cap587.69M
Analysts0
Price TargetN/A
Short Float %0.18%
Short Ratio0.6
Dividend
Industry RankSector Rank
Dividend Yield 10.59%
Yearly Dividend0.92
Dividend Growth(5Y)-5.11%
DP76.8%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-22 2025-08-22 (0.095)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.15
Fwd PE N/A
P/S 8.94
P/FCF 11.56
P/OCF 11.56
P/B 0.95
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)1.24
EY12.27%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.87
FCFY8.65%
OCF(TTM)0.87
OCFY8.65%
SpS1.13
BVpS10.62
TBVpS10.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.19%
ROE 11.56%
ROCE 4.97%
ROIC 3.92%
ROICexc 3.92%
ROICexgc 3.93%
OM 65.77%
PM (TTM) 108.65%
GM 66.08%
FCFM 77.39%
ROA(3y)-4.11%
ROA(5y)0.31%
ROE(3y)-5.67%
ROE(5y)0.48%
ROIC(3y)4.01%
ROIC(5y)3.96%
ROICexc(3y)4.01%
ROICexc(5y)3.96%
ROICexgc(3y)4.03%
ROICexgc(5y)3.97%
ROCE(3y)5.14%
ROCE(5y)5.17%
ROICexcg growth 3Y3.16%
ROICexcg growth 5Y-0.64%
ROICexc growth 3Y3.28%
ROICexc growth 5Y-0.54%
OM growth 3Y-5.61%
OM growth 5Y-2.37%
PM growth 3Y19.94%
PM growth 5YN/A
GM growth 3Y-5.63%
GM growth 5Y-2.25%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 4.92
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 71.23%
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 1.03
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)149.96%
EPS 3Y16.13%
EPS 5YN/A
EPS Q2Q%14.91%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.04%
Revenue growth 3Y-4.32%
Revenue growth 5Y-5.61%
Sales Q2Q%10.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.24%
EBIT growth 3Y-9.69%
EBIT growth 5Y-7.85%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-70.23%
FCF growth 3Y-18.12%
FCF growth 5Y3.58%
OCF growth 1Y-70.23%
OCF growth 3Y-18.12%
OCF growth 5Y3.58%